Trial Profile
Fulvestrant in women with systemic lupus erythematosus with moderate disease activity
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2011
Price :
$35
*
At a glance
- Drugs Fulvestrant (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 02 Mar 2011 New trial record